Section on Pathophysiology and Molecular Pharmacology, Joslin Diabetes Center, Boston, MA, USA.
Department of Microbiology, Harvard Medical School, Boston, MA, USA.
Microbiome. 2022 Dec 9;10(1):218. doi: 10.1186/s40168-022-01373-1.
The gut microbiome promotes specific immune responses, and in turn, the immune system has a hand in shaping the microbiome. Cancer and autoimmune diseases are two major disease families that result from the contrasting manifestations of immune dysfunction. We hypothesized that the opposing immunological profiles between cancer and autoimmunity yield analogously inverted gut microbiome signatures. To test this, we conducted a systematic review and meta-analysis on gut microbiome signatures and their directionality in cancers and autoimmune conditions.
We searched PubMed, Web of Science, and Embase to identify relevant articles to be included in this study. The study was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statements and PRISMA 2009 checklist. Study estimates were pooled by a generic inverse variance random-effects meta-analysis model. The relative abundance of microbiome features was converted to log fold change, and the standard error was calculated from the p-values, sample size, and fold change.
We screened 3874 potentially relevant publications. A total of 82 eligible studies comprising 37 autoimmune and 45 cancer studies with 4208 healthy human controls and 5957 disease cases from 27 countries were included in this study. We identified a set of microbiome features that show consistent, opposite directionality between cancers and autoimmune diseases in multiple studies. Fusobacterium and Peptostreptococcus were the most consistently increased genera among the cancer cases which were found to be associated in a remarkable 13 (+0.5 log fold change in 5 studies) and 11 studies (+3.6 log fold change in 5 studies), respectively. Conversely, Bacteroides was the most prominent genus, which was found to be increased in 12 autoimmune studies (+0.2 log fold change in 6 studies) and decreased in six cancer studies (-0.3 log fold change in 4 studies). Sulfur-metabolism pathways were found to be the most frequent pathways among the member of cancer-increased genus and species.
The surprising reproducibility of these associations across studies and geographies suggests a shared underlying mechanism shaping the microbiome across cancers and autoimmune diseases. Video Abstract.
肠道微生物组促进特定的免疫反应,而反过来,免疫系统也参与塑造微生物组。癌症和自身免疫性疾病是两种主要的疾病家族,它们是免疫功能失调的两种截然不同的表现。我们假设癌症和自身免疫之间相反的免疫特征会产生类似的相反的肠道微生物组特征。为了验证这一点,我们对癌症和自身免疫性疾病中的肠道微生物组特征及其方向性进行了系统评价和荟萃分析。
我们在 PubMed、Web of Science 和 Embase 上搜索了相关文章,以确定纳入本研究的文章。该研究按照系统评价和荟萃分析(PRISMA)的首选报告项目和 PRISMA 2009 清单进行。通过通用逆方差随机效应荟萃分析模型对研究估计值进行汇总。微生物组特征的相对丰度转换为对数倍变化,标准误差由 p 值、样本量和倍变化计算得出。
我们筛选了 3874 篇可能相关的文献。共有 82 项符合条件的研究,包括来自 27 个国家的 37 项自身免疫性疾病研究和 45 项癌症研究,共有 4208 名健康对照者和 5957 名疾病患者。我们确定了一组微生物组特征,这些特征在多种研究中显示出癌症和自身免疫性疾病之间的一致性、相反的方向性。梭菌属和消化链球菌属是癌症病例中最一致增加的属,在 5 项研究中显著相关(5 项研究中为+0.5 对数倍变化)和 11 项研究(在 5 项研究中为+3.6 对数倍变化)。相反,拟杆菌属是最突出的属,在 12 项自身免疫性研究中发现增加(在 6 项研究中为+0.2 对数倍变化),在 6 项癌症研究中减少(在 4 项研究中为-0.3 对数倍变化)。硫代谢途径是癌症增加的属和种中最常见的途径。
这些关联在研究和地理上的惊人重现性表明,在癌症和自身免疫性疾病中,有一个共同的潜在机制在塑造微生物组。视频摘要。